InterWest Venture Management’s MacroGenics MGNX Stock Holding History

InterWest Venture Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-1,074,316	Closed	-$6.25M	–	12
2020 Q1	$6.25M	Hold	1,074,316	–	–	6.61%	3
2019 Q4	$11.7M	Hold	1,074,316	–	–	5.04%	3
2019 Q3	$13.7M	Hold	1,074,316	–	–	5.26%	3
2019 Q2	$18.2M	Hold	1,074,316	–	–	5.89%	3
2019 Q1	$19.3M	Hold	1,074,316	–	–	17.74%	2
2018 Q4	$13.6M	Hold	1,074,316	–	–	19.16%	2
2018 Q3	$23M	Hold	1,074,316	–	–	11.25%	3
2018 Q2	$22.2M	Hold	1,074,316	–	–	9.37%	4
2018 Q1	$27M	Hold	1,074,316	–	–	11.39%	3
2017 Q4	$20.4M	Hold	1,074,316	–	–	6.98%	4
2017 Q3	$19.9M	Hold	1,074,316	–	–	5.17%	4
2017 Q2	$18.8M	Hold	1,074,316	–	–	4.45%	4
2017 Q1	$20M	Hold	1,074,316	–	–	4.25%	4
2016 Q4	$22M	Buy	+1,074,316	New	+$27M	5.24%	3

Other funds holding MGNX

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

InterWest Venture Management's MGNX Position: Q2 2020 in Review

InterWest Venture Management sold out of MacroGenics (MGNX) in Q2 2020, closing a stake of 1,074,316 shares — an estimated $6.25M sold.

InterWest Venture Management first reported a position in MGNX in Q4 2016 and held it in 14 quarters. The position peaked at $27M in Q1 2018. 137 funds tracked by Wall St. Rank hold MGNX as of Q2 2020.

InterWest Venture Management reported no remaining MacroGenics position as of Q2 2020 after selling out during the quarter.
InterWest Venture Management sold 1,074,316 MacroGenics shares in Q2 2020, an estimated $6.25M.
InterWest Venture Management first reported a position in MacroGenics in Q4 2016 and held it in 14 quarters.
InterWest Venture Management's MacroGenics position peaked at $27M in Q1 2018.
137 funds tracked by Wall St. Rank held MacroGenics as of Q2 2020.

Based on InterWest Venture Management's 13F filing for Q2 2020, filed 23 Jul 2020.